Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

Yeon-Sook KimChungnam National University, Daejeon, South Korea;

Shinichi OkaNational Center for Global Health and Medicine Hospital, Tokyo, Japan;

Ploenchan ChetchotisakdKhon Kaen University, Khon Kaen, Thailand;

Amanda ClarkeBrighton and Sussex University Hospitals NHS Trust, Brighton, UK;

Khuanchai SupparatpinyoChiang Mai University, Chiang Mai, Thailand;

Anchalee AvihingsanonThai Red Cross AIDS Research Centre, Bangkok, Thailand;

Winai RatanasuwanSiriraj Hospital, Mahidol University, Bangkok, Thailand;

Sasisopin KiertiburanakulRamathibodi Hospital, Mahidol University, Bangkok, Thailand;

Kiat RuxrungthamThai Red Cross AIDS Research Centre (HIV-NAT), Bangkok, Thailand;

SangYoun YangGilead Sciences, Foster City, California, USA

Susan GuoGilead Sciences, Foster City, California, USA

YaPei LiuGilead Sciences, Foster City, California, USA

Moupali DasGilead Sciences, Foster City, California, USA

Do TranGilead Sciences, Foster City, California, USACorrespondence[email protected]

Damian McCollGilead Sciences, Foster City, California, USA

Roberto CoralesGilead Sciences, Foster City, California, USA

Chris NguyenGilead Sciences, Foster City, California, USA

David PiontkowskyGilead Sciences, Foster City, California, USA

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.